Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Harvard Business School
Argus Health
Express Scripts
Boehringer Ingelheim

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019033

« Back to Dashboard

NDA 019033 describes BRETYLIUM TOSYLATE, which is a drug marketed by Abraxis Pharm, Astrazeneca, Eurohlth Intl Sarl, Hospira, Intl Medication, Luitpold, West-ward Pharms Int, Abbott, B Braun, Baxter Hlthcare, and Hospira Inc, and is included in fifteen NDAs. Additional details are available on the BRETYLIUM TOSYLATE profile page.

The generic ingredient in BRETYLIUM TOSYLATE is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for 019033
Ingredient:bretylium tosylate
Medical Subject Heading (MeSH) Categories for 019033

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Apr 29, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.